Ferroptosis-IN-18
Ferroptosis-IN-18 (51), a promethazine derivative, shows strong anti-ferroptosis and anti-oxidant properties. Ferroptosis-IN-18 (51) can be used in the research for intracerebral hemorrhage (ICH).
For research use only. We do not sell to patients.
- CAS No.: 2247525-20-6
- Formula: C25H27N3S
- Molecular Weight:401.57
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
GPX4 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-375 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human A-375 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human A-375 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| Bel-7402 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| BJ | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human BJ cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human BJ cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| BXPC-3 | EC50 |
2.925 nM
Compound: 51
|
Inhibition of erastin-induced ferroptosis in human BXPC-3 cells assessed as cell viability incubated for 48 hrs by MTT assay
Inhibition of erastin-induced ferroptosis in human BXPC-3 cells assessed as cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33065375] |
| Calu-1 | EC50 |
1.879 nM
Compound: 51
|
Inhibition of erastin-induced ferroptosis in human Calu-1 cells assessed as cell viability incubated for 48 hrs by MTT assay
Inhibition of erastin-induced ferroptosis in human Calu-1 cells assessed as cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33065375] |
| CHL-1 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human CHL-1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human CHL-1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| DU-145 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human DU-145 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human DU-145 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| HaCaT | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human HaCaT cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human HaCaT cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| HEK-293T | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| HT-1080 | EC50 |
0.0005 μM
Compound: 51
|
Inhibition of erastin-induced ferroptosis in human HT-1080 cells assessed as cell viability incubated for 48 hrs by MTT assay
Inhibition of erastin-induced ferroptosis in human HT-1080 cells assessed as cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33065375] |
| HT-1080 | EC50 |
0.5 nM
Compound: 51
|
Inhibition of erastin-induced ferroptosis in human HT-1080 cells assessed as cell viability incubated for 48 hrs by MTT assay
Inhibition of erastin-induced ferroptosis in human HT-1080 cells assessed as cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33065375] |
| Huh-7 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| HUVEC | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against HUVEC assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against HUVEC assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| K562 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| L02 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human L02 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human L02 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| Malme-3M | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human Malme-3M cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human Malme-3M cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| MDA-MB-231 | EC50 |
0.424 nM
Compound: 51
|
Inhibition of erastin-induced ferroptosis in human MDA-MB-231 cells assessed as cell viability incubated for 48 hrs by MTT assay
Inhibition of erastin-induced ferroptosis in human MDA-MB-231 cells assessed as cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33065375] |
| MDA-MB-231 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| MDA-MB-435 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| NCI-H1975 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human NCI-H1975 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human NCI-H1975 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| NCI-H23 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human NCI-H23 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human NCI-H23 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| PC-9 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human PC-9 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human PC-9 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| SK-OV-3 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| U-251 | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human U-251 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human U-251 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
| U-87MG ATCC | IC50 |
>10 μM
Compound: 51
|
Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 33065375] |
Ferroptosis-IN-18 (51) increases cell viability and GPX4 levels[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2247525-20-6
-
Molecular Weight 401.57
-
Formula C25H27N3S
-
SMILES
CC(C(C=C1N2)=CC=C1SC3=C2C=CC=C3)C4=CC=C(N5CCN(C)CC5)C=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)